Director, Regional Market Access & Partnerships

CSL seeks a Director, Regional Ecosystem Lead to drive strategic partnerships and market development for our biotechnology and pharmaceutical portfolio. In this role, you will shape regional ecosystem strategy across healthcare providers, payers, patient organizations, and policy stakeholders to expand access to CSL’s biotherapies, vaccines, and plasma‑derived therapies. You will analyze market dynamics, identify growth opportunities, and guide cross‑functional teams in commercial, medical, and market access. This position requires strong leadership, stakeholder management, and a deep understanding of biotech/pharma markets. Develop and execute regional ecosystem strategy to support CSL’s biotherapies and vaccines Build and manage relationships with providers, payers, patient groups, and policy influencers Analyze market dynamics, competitive landscape, and access barriers to inform strategy Lead cross-functional collaboration with commercial, medical, and market access teams Identify and prioritize regional growth opportunities and partnership models Translate insights into actionable go-to-market and access plans Track performance against regional objectives and adjust strategies as needed Ensure alignment with regulatory, compliance, and ethical standards Provide strategic leadership, coaching, and alignment across regional teams Represent CSL’s patient-focused, science-driven culture in external engagements Biotechnology market strategy Pharmaceutical commercialization Ecosystem and stakeholder mapping Market access and reimbursement Strategic partnership development Data-driven market analytics Regulatory and compliance awareness Cross-functional leadership Portfolio and lifecycle management Financial and P&L acumen Medical Insurance Dental Insurance Vision Insurance Life Insurance 401k MBA or advanced degree in life sciences, health economics, or business preferred PMP or equivalent project leadership credential a plus Training in market access, health economics, or outcomes research advantageous